Cargando…
Protein Changes Contributing to Right Ventricular Cardiomyocyte Diastolic Dysfunction in Pulmonary Arterial Hypertension
BACKGROUND: Right ventricular (RV) diastolic function is impaired in patients with pulmonary arterial hypertension (PAH). Our previous study showed that elevated cardiomyocyte stiffness and myofilament Ca(2+) sensitivity underlie diastolic dysfunction in PAH. This study investigates protein modifica...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309054/ https://www.ncbi.nlm.nih.gov/pubmed/24895160 http://dx.doi.org/10.1161/JAHA.113.000716 |
_version_ | 1782354627060039680 |
---|---|
author | Rain, Silvia Bos, Denielli da Silva Goncalves Handoko, M. Louis Westerhof, Nico Stienen, Ger Ottenheijm, Coen Goebel, Max Dorfmüller, Peter Guignabert, Christophe Humbert, Marc Bogaard, Harm‐Jan dos Remedios, Cris Saripalli, Chandra Hidalgo, Carlos G. Granzier, Henk L. Vonk‐Noordegraaf, Anton van der Velden, Jolanda de Man, Frances S. |
author_facet | Rain, Silvia Bos, Denielli da Silva Goncalves Handoko, M. Louis Westerhof, Nico Stienen, Ger Ottenheijm, Coen Goebel, Max Dorfmüller, Peter Guignabert, Christophe Humbert, Marc Bogaard, Harm‐Jan dos Remedios, Cris Saripalli, Chandra Hidalgo, Carlos G. Granzier, Henk L. Vonk‐Noordegraaf, Anton van der Velden, Jolanda de Man, Frances S. |
author_sort | Rain, Silvia |
collection | PubMed |
description | BACKGROUND: Right ventricular (RV) diastolic function is impaired in patients with pulmonary arterial hypertension (PAH). Our previous study showed that elevated cardiomyocyte stiffness and myofilament Ca(2+) sensitivity underlie diastolic dysfunction in PAH. This study investigates protein modifications contributing to cellular diastolic dysfunction in PAH. METHODS AND RESULTS: RV samples from PAH patients undergoing heart‐lung transplantation were compared to non‐failing donors (Don). Titin stiffness contribution to RV diastolic dysfunction was determined by Western‐blot analyses using antibodies to protein‐kinase‐A (PKA), Cα (PKCα) and Ca(2+)/calmoduling‐dependent‐kinase (CamKIIδ) titin and phospholamban (PLN) phosphorylation sites: N2B (Ser469), PEVK (Ser170 and Ser26), and PLN (Thr17), respectively. PKA and PKCα sites were significantly less phosphorylated in PAH compared with donors (P<0.0001). To test the functional relevance of PKA‐, PKCα‐, and CamK(IIδ)‐mediated titin phosphorylation, we measured the stiffness of single RV cardiomyocytes before and after kinase incubation. PKA significantly decreased PAH RV cardiomyocyte diastolic stiffness, PKCα further increased stiffness while CamK(IIδ) had no major effect. CamKIIδ activation was determined indirectly by measuring PLN Thr17phosphorylation level. No significant changes were found between the groups. Myofilament Ca(2+) sensitivity is mediated by sarcomeric troponin I (cTnI) phosphorylation. We observed increased unphosphorylated cTnI in PAH compared with donors (P<0.05) and reduced PKA‐mediated cTnI phosphorylation (Ser22/23) (P<0.001). Finally, alterations in Ca(2+)‐handling proteins contribute to RV diastolic dysfunction due to insufficient diastolic Ca(2+) clearance. PAH SERCA2a levels and PLN phosphorylation were significantly reduced compared with donors (P<0.05). CONCLUSIONS: Increased titin stiffness, reduced cTnI phosphorylation, and altered levels of phosphorylation of Ca(2+) handling proteins contribute to RV diastolic dysfunction in PAH. |
format | Online Article Text |
id | pubmed-4309054 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-43090542015-01-28 Protein Changes Contributing to Right Ventricular Cardiomyocyte Diastolic Dysfunction in Pulmonary Arterial Hypertension Rain, Silvia Bos, Denielli da Silva Goncalves Handoko, M. Louis Westerhof, Nico Stienen, Ger Ottenheijm, Coen Goebel, Max Dorfmüller, Peter Guignabert, Christophe Humbert, Marc Bogaard, Harm‐Jan dos Remedios, Cris Saripalli, Chandra Hidalgo, Carlos G. Granzier, Henk L. Vonk‐Noordegraaf, Anton van der Velden, Jolanda de Man, Frances S. J Am Heart Assoc Original Research BACKGROUND: Right ventricular (RV) diastolic function is impaired in patients with pulmonary arterial hypertension (PAH). Our previous study showed that elevated cardiomyocyte stiffness and myofilament Ca(2+) sensitivity underlie diastolic dysfunction in PAH. This study investigates protein modifications contributing to cellular diastolic dysfunction in PAH. METHODS AND RESULTS: RV samples from PAH patients undergoing heart‐lung transplantation were compared to non‐failing donors (Don). Titin stiffness contribution to RV diastolic dysfunction was determined by Western‐blot analyses using antibodies to protein‐kinase‐A (PKA), Cα (PKCα) and Ca(2+)/calmoduling‐dependent‐kinase (CamKIIδ) titin and phospholamban (PLN) phosphorylation sites: N2B (Ser469), PEVK (Ser170 and Ser26), and PLN (Thr17), respectively. PKA and PKCα sites were significantly less phosphorylated in PAH compared with donors (P<0.0001). To test the functional relevance of PKA‐, PKCα‐, and CamK(IIδ)‐mediated titin phosphorylation, we measured the stiffness of single RV cardiomyocytes before and after kinase incubation. PKA significantly decreased PAH RV cardiomyocyte diastolic stiffness, PKCα further increased stiffness while CamK(IIδ) had no major effect. CamKIIδ activation was determined indirectly by measuring PLN Thr17phosphorylation level. No significant changes were found between the groups. Myofilament Ca(2+) sensitivity is mediated by sarcomeric troponin I (cTnI) phosphorylation. We observed increased unphosphorylated cTnI in PAH compared with donors (P<0.05) and reduced PKA‐mediated cTnI phosphorylation (Ser22/23) (P<0.001). Finally, alterations in Ca(2+)‐handling proteins contribute to RV diastolic dysfunction due to insufficient diastolic Ca(2+) clearance. PAH SERCA2a levels and PLN phosphorylation were significantly reduced compared with donors (P<0.05). CONCLUSIONS: Increased titin stiffness, reduced cTnI phosphorylation, and altered levels of phosphorylation of Ca(2+) handling proteins contribute to RV diastolic dysfunction in PAH. Blackwell Publishing Ltd 2014-06-03 /pmc/articles/PMC4309054/ /pubmed/24895160 http://dx.doi.org/10.1161/JAHA.113.000716 Text en © 2014 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/3.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Research Rain, Silvia Bos, Denielli da Silva Goncalves Handoko, M. Louis Westerhof, Nico Stienen, Ger Ottenheijm, Coen Goebel, Max Dorfmüller, Peter Guignabert, Christophe Humbert, Marc Bogaard, Harm‐Jan dos Remedios, Cris Saripalli, Chandra Hidalgo, Carlos G. Granzier, Henk L. Vonk‐Noordegraaf, Anton van der Velden, Jolanda de Man, Frances S. Protein Changes Contributing to Right Ventricular Cardiomyocyte Diastolic Dysfunction in Pulmonary Arterial Hypertension |
title | Protein Changes Contributing to Right Ventricular Cardiomyocyte Diastolic Dysfunction in Pulmonary Arterial Hypertension |
title_full | Protein Changes Contributing to Right Ventricular Cardiomyocyte Diastolic Dysfunction in Pulmonary Arterial Hypertension |
title_fullStr | Protein Changes Contributing to Right Ventricular Cardiomyocyte Diastolic Dysfunction in Pulmonary Arterial Hypertension |
title_full_unstemmed | Protein Changes Contributing to Right Ventricular Cardiomyocyte Diastolic Dysfunction in Pulmonary Arterial Hypertension |
title_short | Protein Changes Contributing to Right Ventricular Cardiomyocyte Diastolic Dysfunction in Pulmonary Arterial Hypertension |
title_sort | protein changes contributing to right ventricular cardiomyocyte diastolic dysfunction in pulmonary arterial hypertension |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309054/ https://www.ncbi.nlm.nih.gov/pubmed/24895160 http://dx.doi.org/10.1161/JAHA.113.000716 |
work_keys_str_mv | AT rainsilvia proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension AT bosdeniellidasilvagoncalves proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension AT handokomlouis proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension AT westerhofnico proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension AT stienenger proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension AT ottenheijmcoen proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension AT goebelmax proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension AT dorfmullerpeter proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension AT guignabertchristophe proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension AT humbertmarc proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension AT bogaardharmjan proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension AT dosremedioscris proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension AT saripallichandra proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension AT hidalgocarlosg proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension AT granzierhenkl proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension AT vonknoordegraafanton proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension AT vanderveldenjolanda proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension AT demanfrancess proteinchangescontributingtorightventricularcardiomyocytediastolicdysfunctioninpulmonaryarterialhypertension |